Oct 21, 2020 6:30am EDT ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab
Oct 13, 2020 6:30am EDT ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference
Sep 10, 2020 6:30am EDT ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Investment Conference
Jul 09, 2020 6:30am EDT ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease
Jun 24, 2020 6:30am EDT ProMIS Neurosciences announces adjournment and change of location of annual meeting of shareholders
Jun 17, 2020 6:30am EDT ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant progress on development of highly accurate antibody test for COVID-19
May 28, 2020 6:30am EDT ProMIS Neurosciences and collaborative team receive Supercluster Award supporting avoidance of future pandemics by new strains of the COVID-19 virus